Literature DB >> 30822569

Drug-induced hypertension: Know the problem to know how to deal with it.

Stefano Masi1, Monica Uliana2, Marco Gesi3, Stefano Taddei1, Agostino Virdis4.   

Abstract

Arterial hypertension remains the world's leading mortality risk factor and despite overwhelming evidence that blood pressure-lowering strategies greatly reduce the cardiovascular risk, a substantial proportion of hypertensive individuals worldwide fail to achieve an optimal blood pressure control under treatment. Among the causes responsible for the gap existing between blood pressure lowering potential of the different antihypertensive treatments and real-life practice is the presence of drug-induced hypertension. Many therapeutic agents or substances may directly favour an increment of blood pressure values or counteract the blood pressure lowering effects of antihypertensive drugs. Excessive water and sodium retention, direct vasoconstriction or sympathomimetic activation are major mechanisms of action of such substances. The present manuscript will review medications and other substances that may increase blood pressure, also suggesting the choice of the more appropriate antihypertensive agents to employ when withdrawal of the substance or drug causing an elevation of blood pressure values is not possible.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclosporine; Drug-induced hypertension; Medications; Sympathomimetic activation

Mesh:

Substances:

Year:  2019        PMID: 30822569     DOI: 10.1016/j.vph.2019.02.002

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  1 in total

1.  Current Status of Adverse Event Profile of Cyclosporine in Kidney, Stem Cell, and Heart Transplantations Using the Japanese Pharmacovigilance Database.

Authors:  Iku Niinomi; Saki Oyama; Ayaka Inada; Tomohito Wakabayashi; Tatsuya Iida; Hiroko Kambara; Mayako Uchida; Yukako Sano; Keiko Hosohata
Journal:  Cureus       Date:  2022-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.